Shai Karmi

LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel.

Giza Venture Capital (Giza Venture) is a venture capital firm founded in 1992 by Zeev Holtzman and Zvi Schechter. The firm is headquartered in Tel Aviv, Israel.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

Swanlaab Venture Factory SGEIC SA (Swanlaab Venture Factory) is an Independent Venture Capital firm founded in 2014. It is headquartered in Alcobendas, Spain.

Crescendo Venture Partners (Crescendo Venture) is a venture capital firm founded in 2018. The firm is headquartered in Tel-Aviv, Israel.

NeuReality Ltd. provides purpose-built AI hardware and software solutions that make it easy to deploy, manage, and scale AI workflows. The company is based in Caesarea, Israel. The Israeli company offers holistic solutions for inference deployment, lowering the complexity, cost, and energy use of AI inference. NeuReality was founded by Yossi Kasus, Moshe Tanach, and Tzvika Shmueli, with Moshe Tanach serving as CEO since incorporation.